NCAM1 and pulmonary fibrosis: Our data indicates that the phenotype of CD16-CD56 positive NK cells is associated with a reduced risk of pulmonary fibrosis, suggesting that NK cells play a positive role in antifibrosis by mitigating tissue damage and promoting tissue repair.